Burkitt Lymphoma

• CLINICAL_TRIALS trial_result · 2013-01-07
  Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function [Phase 1]

  Phase 1 trial of sorafenib in patients with metastatic or unresectable solid tumors, multiple myeloma, or non-Hodgkin lymphomas; the study h…

• CLINICAL_TRIALS trial_result · 2012-10-19
  Clinical Trial Update: MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma [Phase 1, Phase 2]

  This clinical trial update reports on MDX-010 (ipilimumab) in treating recurrent or refractory lymphoma across multiple subtypes, with the s…

• CLINICAL_TRIALS trial_result · 2012-09-19
  Clinical Trial Update: PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma [Phase 2]

  Phase 2 trial of belinostat (PXD101) in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma has completed, with results posted in …

• CLINICAL_TRIALS trial_result · 2012-08-27
  Clinical Trial Update: Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy [NA]

  A completed randomized trial comparing Procrit (epoetin alfa) versus no Procrit in patients with acute lymphoblastic leukemia, lymphoblastic…

• CLINICAL_TRIALS trial_result · 2012-07-31
  Clinical Trial Update: Coproporphyrine Isomers and Methotrexate Elimination

  This completed clinical trial update investigates coproporphyrin isomer profiles and methotrexate elimination in patients with Central Nervo…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-01-20
  Clinical Trial Update: Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia [Phase 2]

  Phase 2 clinical trial update for the CLAG-M regimen (cladribine, cytarabine, mitoxantrone, filgrastim) in relapsed acute lymphoblastic leuk…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas [Phase 2]

  Clinical trial update reporting completion of a Phase 2 pilot protocol for the treatment of Burkitt lymphoma and diffuse large B-cell lympho…

• CLINICAL_TRIALS trial_result · 2006-09-11
  Clinical Trial Update: Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL [Phase 2]

  A Phase 2 trial of rituximab in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma (Burkitt lymphoma) has been…